TY - JOUR
T1 - Burden of disease of COVID-19: strengthening the collaboration for national studies
AU - Pires, Sara Monteiro
AU - Wyper, Grant M A
AU - Wengler, Annelene
AU - Peñalvo, José L
AU - Haneef, Romana
AU - Moran, Declan
AU - Cuschieri, Sarah
AU - Redondo, Hernan G
AU - De Pauw, Robby
AU - McDonald, Scott A
AU - Moon, Lynelle
AU - Shedrawy, Jad
AU - Pallari, Elena
AU - Charalampous, Periklis
AU - Devleesschauwer, Brecht
AU - Von Der Lippe, Elena
N1 - FTX; Copyright © 2022 Pires, Wyper, Wengler, Peñalvo, Haneef, Moran, Cuschieri, Redondo, De Pauw, McDonald, Moon, Shedrawy, Pallari, Charalampous, Devleesschauwer and Von Der Lippe. (CC BY 4.0)
PY - 2022
Y1 - 2022
N2 - Objectives: Quantifying the combined impact of morbidity and mortality is a key enabler to assessing the impact of COVID-19 across countries and within countries relative to other diseases, regions, or demographics. Differences in methods, data sources, and definitions of mortality due to COVID-19 may hamper comparisons. We describe efforts to support countries in estimating the national-level burden of COVID-19 using disability-adjusted life years.Methods: The European Burden of Disease Network developed a consensus methodology, as well as a range of capacity-building activities to support burden of COVID-19 studies. These activities have supported 11 national studies so far, with study periods between January 2020 and December 2021.Results: National studies dealt with various data gaps and different assumptions were made to face knowledge gaps. Still, they delivered broadly comparable results that allow for interpretation of consistencies, as well as differences in the quantified direct health impact of the pandemic.Discussion: Harmonized efforts and methodologies have allowed for comparable estimates and communication of results. Future studies should evaluate the impact of interventions, and unravel the indirect health impact of the COVID-19 crisis.
AB - Objectives: Quantifying the combined impact of morbidity and mortality is a key enabler to assessing the impact of COVID-19 across countries and within countries relative to other diseases, regions, or demographics. Differences in methods, data sources, and definitions of mortality due to COVID-19 may hamper comparisons. We describe efforts to support countries in estimating the national-level burden of COVID-19 using disability-adjusted life years.Methods: The European Burden of Disease Network developed a consensus methodology, as well as a range of capacity-building activities to support burden of COVID-19 studies. These activities have supported 11 national studies so far, with study periods between January 2020 and December 2021.Results: National studies dealt with various data gaps and different assumptions were made to face knowledge gaps. Still, they delivered broadly comparable results that allow for interpretation of consistencies, as well as differences in the quantified direct health impact of the pandemic.Discussion: Harmonized efforts and methodologies have allowed for comparable estimates and communication of results. Future studies should evaluate the impact of interventions, and unravel the indirect health impact of the COVID-19 crisis.
U2 - 10.3389/fpubh.2022.907012
DO - 10.3389/fpubh.2022.907012
M3 - A1: Web of Science-article
C2 - 35734754
SN - 2296-2565
VL - 10
JO - Frontiers in Public Health
JF - Frontiers in Public Health
M1 - 907012
ER -